Clinical trial
Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer…
NCT00216034 · Hokuriku-Kinki Immunochemotherapy Study Group, Other · Completed
Key facts
| NCT number | NCT00216034 |
|---|---|
| Title | Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK |
| Official title | Randomized Multicenter Controlled Phase III Study of Postoperative Adjuvant Therapy for Stage II/IIIA Gastric Cancer Using TS-1 Alone or TS-1+PSK Combined Therapy |
| Lead sponsor | Hokuriku-Kinki Immunochemotherapy Study Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug |
| Interventions | Tegafur-gimeracil-oteracil potassium (TS-1), Krestin (PSK) |
| Enrollment | 255 |
| Start date | Mar 1, 2005 |
| Primary completion | Feb 1, 2016 |
| Completion | Feb 1, 2016 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 7, 2016 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: